journal article·2019-12-04Open access

In-vitro haemocompatibility of dextran-protein submicron particles

Chiraphat Kloypan, Nittiya Suwannasom, Saranya Chaiwaree, Ausanai Prapan, Kathrin Smuda, Nuttakorn Baisaeng, Axel Pruß, Radostina Georgieva, Hans Bäumler

Abstract

Blood compatibility is a key requirement to fulfil for intravenous administration of drug and oxygen carrier system. Recently, we published the fabrication of oxidised-dextran (Odex)-crosslinked protein particles by one-pot formulation. In the current study we investigate the haemocompatibility of these Odex - particles including albumin particles (Odex-APs) and haemoglobin particles (Odex-HbMPs). Odex-APs and Odex-HbMPs have a submicron size ranged 800-1000 nm with peanut-like shape and a negative surface charge. In vitro haemocompatibility assays included haemolysis test, indirect phagocytosis test and platelet activation test in human blood. Odex-APs and Odex-HbMPs did not provoke any undesirable effects on the blood cells. Firstly, the ratio of haemolysis after contacted with Odex-crosslinked protein particles were less than 5% and therefore the particles may be considered non-haemolytic. Secondly, the incubation of leukocyte with Odex-APs/HbMPs did not influence the phagocytosis of leukocyte. We conclude that our particles are not recognized by monocytes or granulocytes. Finally, exposure of Odex-APs/HbMPs to platelets did not cause an activation of platelets. Additionally, Odex-HbMP/AP did not enhance or attenuate agonist-induced platelet activation. We conclude that Odex-crosslinked protein particles exhibit a very good haemocompatibility and represent highly promising carriers for drugs or oxygen.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Hemostasis and retained surgical items

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin

Division of Clinical Immunology and Transfusion Sciences, School of Allied Health Sciences, University of Phayao

Division of Biochemistry and Nutrition, School of Medical Sciences, University of Phayao

Department of Radiological Technology, Faculty of Allied Health Sciences, Naresuan University

Department of Pharmaceutical Technology, Faculty of Pharmacy, Payap University

Division of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of Phayao

Department of Medical Physics, Biophysics and Radiology, Faculty of Medicine, Trakia University

References (37)

Show source-provided references
1. 10.3390/ma1005051710.3390/ma10050517 ↗
2. 10.3390/ijms1401162910.3390/ijms14011629 ↗
3. 10.1016/j.jconrel.2012.04.03610.1016/j.jconrel.2012.04.036 ↗
4. 10.1016/j.jconrel.2011.07.03110.1016/j.jconrel.2011.07.031 ↗
5. 10.1155/2014/18054910.1155/2014/180549 ↗
6. 10.1016/j.addr.2007.08.04410.1016/j.addr.2007.08.044 ↗
7. 10.1016/j.msec.2017.08.00410.1016/j.msec.2017.08.004 ↗
8. 10.1021/bm301085x10.1021/bm301085x ↗
9. 10.1111/aor.1233110.1111/aor.12331 ↗
10. 10.1021/nn402073n10.1021/nn402073n ↗
11. 10.1002/adma.20150258110.1002/adma.201502581 ↗
12. 10.1016/j.tibtech.2014.05.00110.1016/j.tibtech.2014.05.001 ↗
13. De Frates K, Markiewicz T, Gallo P, et al. Protein polymer-based nanoparticles: fabrication and medical applications. Int J Mol Sci. 2018;19:1–20.
14. 10.1021/nn301735u10.1021/nn301735u ↗
15. 10.1021/bc800431d10.1021/bc800431d ↗
16. 10.1016/j.bbapap.2008.03.01310.1016/j.bbapap.2008.03.013 ↗
17. 10.1016/j.biomaterials.2011.08.01510.1016/j.biomaterials.2011.08.015 ↗
18. 10.1021/mp800032f10.1021/mp800032f ↗
19. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
20. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
21. 10.1016/j.tox.2009.01.01510.1016/j.tox.2009.01.015 ↗
22. Lundqvist M, Stigler J, Elia G, et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Appl Phys Sci. 2008;105:14265–14270.
23. 10.1080/21691401.2018.152181910.1080/21691401.2018.1521819 ↗
24. 10.1002/mabi.20120002310.1002/mabi.201200023 ↗
25. 10.1177/088532821350967610.1177/0885328213509676 ↗
26. 10.1016/j.colsurfb.2015.12.01210.1016/j.colsurfb.2015.12.012 ↗
27. 10.3233/CH-14187610.3233/CH-141876 ↗
28. 10.1182/blood-2012-06-43772310.1182/blood-2012-06-437723 ↗
29. 10.1021/bm100112510.1021/bm1001125 ↗
30. 10.1016/j.jcis.2017.12.03010.1016/j.jcis.2017.12.030 ↗
31. 10.1126/science.111439710.1126/science.1114397 ↗
32. 10.1038/nbt.333010.1038/nbt.3330 ↗
33. 10.1586/17434440.2.4.47310.1586/17434440.2.4.473 ↗
34. 10.1111/jth.1242210.1111/jth.12422 ↗
35. 10.1021/acsnano.6b0208610.1021/acsnano.6b02086 ↗
36. 10.3233/BIR-1996-334-50410.3233/BIR-1996-334-504 ↗
37. Bäumler H, Neu B, Donath E, et al. Basic phenomena of red blood cell rouleaux formation. Biorheology. 1999; 36:439–442.